Phospholipids Market
Phospholipids Market Analysis, By Source (Soy, Eggs, Other Sources), By Application (Nutrition and Supplements, Pharmaceutical, Other Applications), and Region - Global Market Insights 2022-2032
Analysis of Phospholipids Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Phospholipids Market Outlook (2022-2032)
The global Phospholipids Market was valued at around US$ 3.7 Billion in 2021. With a projected CAGR of 7.3% for the next ten years, the market is likely to reach a valuation of approximately US$ 7.8 Billion by the end of 2032.
Fact.MR’s analysis reveals that most of the phospholipids industry revenue is grossed from Soy as a source which has a predicted CAGR of 7.8% by 2032. Nutrition and Supplements are the top application of these tests, with a CAGR of 7.4% in the forecast period.
Phospholipids are extensively used across a variety of applications, from pharmaceuticals and vaccines, and drug delivery systems to cosmetics and nutrition. This widespread usage, as well as the increase in funding for research and production by authorities, is expected to be the key driver for demand in the forecast period.
Report Attributes |
Details |
|
Global Market Size (2021A) |
US$ 3.6 Billion |
|
Estimated Market Value (2022E) |
US$ 3.8 Billion |
|
Forecasted Market Value (2032) |
US$ 7.8 Billion |
|
Global Market Growth Rate (2022-2032) |
7.3% CAGR |
|
United States Forecasted Market Value (2032) |
US$ 2.5 Billion |
|
United States Growth Rate(2022-2032) |
7.7% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
How are dietary concerns boosting demand for phospholipids in the nutrition and supplements segment?
The Nutrition and Supplements segment accounted for 61.5% of the market revenue in 2021, with a forecasted CAGR of 7.4% in the next decade. The use of phospholipids in supplements and nutrition has been gaining prominence as an increasing amount of research indicates their importance. Phospholipids form a shell around necessary fats and fat-soluble nutrients such as omega-3 fatty acids, which aid in the distribution and absorption by the body.
They are naturally found in meat, eggs, and seafood, but are also taken as supplements. Krill is a popular source, containing 40% phospholipids. Research has also suggested that the omega-3s DHA and EPA from krill oil, which is bound to phospholipids instead of to triglycerides as they are in fish oil, might show higher bioavailability. The increase in usage of supplements as research indicates their importance widens is expected to boost demand.
How has use in Drug delivery systems given a boost to the market?
The use of Phospholipids in Drug Delivery Systems has been a key contributor to demand. The key concern when designing drug delivery systems is to create a product that can allow the substance to reach the site of action while avoiding the rest of the host tissue. Phospholipids have good biocompatibility and their amphiphilic nature means they have excellent characteristics for use in these systems, such as self-assembly, Emulsification, and wetting abilities. The wetting ability in particular is useful in the usage to enhance the hydrophilicity of hydrophobic drugs.
Phospholipids also have the ability to form liposomes, which have wide usage in drug-carrying applications. Liposomes can deliver a wide variety of drugs, antifungal, and analgesic, both hydrophilic and lipophilic types of drugs, can target the site of action efficiently, improve the stability of the drug and reduce drug toxicity.
Phospholipids are also used in drugs that have dermal administration since they enhance the skin barrier and moisturize the skin. They also increase the retention time for the drugs.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
How has the use of phospholipids in mRNA-based vaccines affected the phospholipids market?
Despite the lull due to supply chain interruptions, COVID-19 led to a boost in demand due to the nature of phospholipids as an important component in the mRNA-based COVID-19 vaccines. mRNA technology, which uses a copy of the messenger RNA to produce an immune response, uses lipids. This is because RNA is widely regarded as fragile, since they are seen as intrinsically less stable when compared with DNA, and can degrade pre-emptively and even cause an unwanted immune reaction.
mRNA developers use a combination of lipids to form liquid nanoparticles or LNPs in order to ensure the mRNA reaches the target cells. The 4-lipid package used in mRNA vaccination includes, amongst the other lipids, DSPC or di-stearoyl phosphatidylcholine which is a structure-forming phospholipid. With the global pandemic, several authorities are encouraging research and development efforts for the same, giving a significant boost to demand.
Why has there been a surge in the usage of phospholipids in the cosmetic industry?
Phospholipids are gaining popularity in the cosmetic industry, Phospholipids are natural humectants. They are hygroscopic substances that can pull in water and can lock in moisture to hydrate and improve the skin barrier function. While monoacylphospholipids are mostly used only as emulsifiers, saturated and unsaturated phospholipids have a variety of applications, with the unsaturated type finding more usage in the enhancement of skin protection and as actives the unsaturated type finding use as surface-active compounds. Research also indicates their potential both as antioxidants and in the enhancing delivery of other cosmetics.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is the boost in demand for lecithin affecting the market?
Commercial lecithin is a complex mixture of phospholipids and oil. It is being used in varied applications, such as use as emulsification and dispersion agents. Lecithin’s amphiphilic nature, with the ability to attract both water and fatty substances, means it also has widespread application in other uses, such as emulsifying infusion solutions, the synthesis of liposomes, and others. Lecithin is commonly used in applications that require the mixing of fats with other liquids or solids, such as in confectionery and baking applications.
Region-Wise Insights
How is Europe an emerging market for demand?
Europe is an emerging market for the demand for Phospholipids. According to the European Commission, lecithin is categorized as an E322 food additive with no fixed ADI value. This means lecithin is allowed for quantum satis use. Germany is a key country for demand, having witnessed a CAGR of 5.9% and having a forecasted market value of US$ 391 Mn at a CAGR of 7.0%. In April 2022, Wacker and CordenPharma announced that they had won a bid with the German government for the stand-by production of mRNA vaccines. The bid entails the expectation for the two to produce 80 Million doses, which may be increased to 100 Million doses, if required, by 2029.
Country-wise Insights
United States Phospholipids Market Analysis
The United States is a key country for demand, having witnessed a CAGR of 5.5%, with an absolute dollar opportunity of US$ 1.3 Bn and a forecasted 2032 market size of US $2.8 Bn at a CAGR of 7.7%. The FDA assigns a GRAS affirmation for lecithin. In June 2022, Croda International Plc announced an agreement with the US government for the expansion of manufacturing capacity for lipid systems used in novel drug systems. Under this agreement, the US government will provide US$ 75 Mn and Croda will invest US$ 58 Mn for the building of Croda’s lipid facility in the US.
This amount was awarded as a joint award from BARDA, or the Biomedical Research and Development Authority (which is part of the Office of the Assistant Secretary for Preparedness and Response within the US Department of Health and Human Services) and the JPEO-CBRND or the US Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defence in partnership with the ACC JCRD or the Army Contracting Command’s Joint COVID Response Division.
UK Phospholipids Market Analysis
The UK is slowly emerging as a contributor to global demand, having witnessed a CAGR of 6.7%, with an absolute dollar opportunity of US$ 172 Mn and a forecasted 2032 market size of US$ 349 Mn at a CAGR of 7.1%. In March 2022, Croda International Plc announced that it had been awarded a grant of £15.9 million or approximately US$ 20.8 Mn by the U.K. government to increase the production capacity of their specialty lipids at their facility in Leek.
Japan Phospholipids Market Analysis
The market in Japan was held at US$ 155 Mn in 2021. The market in the country is projected to reach a valuation of US$ 315 Mn by 2032, growing at a CAGR of 6.7% during 2022 – 2032. The market during the forecast period is expected to garner an absolute dollar opportunity of US$ 150 Mn.
South Korea Phospholipids Market Analysis
In South Korea, the market is expected to reach a valuation of US$ 189 Mn. The market is projected to gross an absolute dollar opportunity of about US$ 100 Mn during the forecast period, growing at a CAGR of 7.6%.
Category-wise Insights
What is the top source of phospholipids?
Soy-based phospholipids, which are expected to contribute to over 50% of market revenue in 2032, are the top source of phospholipids, having witnessed a CAGR of 5.6% during 2017 – 2021. Soy-based phospholipids are a byproduct of the soybean oil production process. The sludge that remains after soy oil is degummed in the soybean oil manufacturing process is processed either mechanically or chemically to produce Soy Lecithin. Soy lecithin is a cheap form of an emulsifier since soybean is one of the cheapest crops to produce, with several countries even providing subsidies to produce it. Soy lecithin’s popularity is increased by the fact that it is required in small doses to show results.
For example, 0.5% of lecithin can have the same effect on thinning down coating in chocolate that 3.0%-4.0% cocoa butter would have had. The replacement with lecithin is also attractive due to the fact that it can significantly reduce manufacturing costs.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Phospholipids providers are focused on increasing the production of their products to meet demand in widespread applications. The key companies operating include Archer Daniels Midland Company, Croda International Plc, Bunge Ltd., Cargill, Inc., Kewpie Corporation, Lasenor Emul SL, Lecico GmbH, Lipoid GmbH, Sime Darby Unimills B.V. SojaProtein, Stern-Wywiol Gruppe, VAV Life Sciences Pvt. Ltd., and Wilmar International Ltd.
Some of the recent development in Phospholipids are as follows:
- In June 2022, Germany’s LECICO GmbH announced the launching of a soy-sourced phospholipid in the form of phosphatidylcholine. The product was named LIPAMINE PC 30 P IP and was intended for use as a nutraceutical for functional food formulations, as well as an excipient in pharmaceutical and liposomes.
- In June 2022, Evonik Industries announced an agreement with the US government for the expansion of its capacity to manufacture lipids for use in mRNA therapies both in and beyond COVID vaccines.
Under this agreement, there is a total of US$ 220 Mn as investment, from BARDA, or the Biomedical Research and Development Authority providing US$ 150 Mn, with additional support from the IEDC or Indiana Economic Development Corporation, the GLC or the Greater Lafayette Commerce and Duke Energy.
- In November 2021, Bunge Loders Croklaan, the natural, plant-based business from Bunge announced plans to build a production facility in the Port of Amsterdam with a 2024 completion goal.
- In April 2021, VAV Lifesciences through its subsidiary VAV lipids announced an agreement with a US-based Contract Development and Manufacturing or CDMO firm for the supply of phospholipids to be used in mRNA-based COVID vaccine manufacturing. The firm is a vaccine maker for companies like Pfizer-BioNTech and Moderna and will use the phospholipids provided to produce LNPs or Liquid nanoparticles on the behalf of the two.
- In March 2021, Lecico and Ciranda announced an agreement that grants Ciranda an exclusive distribution agreement in the North American Market.
- In January 2021, New Zealand’s Fonterra Co-Operative Group Limited launched milk phospholipids sourced from non-GMO rBST-free and grass-fed cows’ milk. This product is intended for the resolution of mental stress and neutraceuticals.
Similarly, recent developments related to companies manufacturing phospholipids have been tracked by the team at Fact.MR, which is available in the full report.
Key Segments Covered in Phospholipids Survey
-
By Source:
- Soy
- Eggs
- Other Sources
-
By Application:
- Nutrition and Supplements
- Pharmaceuticals
- Other Applications
-
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Source 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Source, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Source, 2022-2032 5.3.1. Soy 5.3.2. Eggs 5.3.3. Other Sources 5.4. Y-o-Y Growth Trend Analysis By Source, 2017-2021 5.5. Absolute $ Opportunity Analysis By Source, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Application, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Application, 2022-2032 6.3.1. Nutrition and Supplements 6.3.2. Pharmaceuticals 6.3.3. Other Applications 6.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 6.5. Absolute $ Opportunity Analysis By Application, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021 7.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. Asia Pacific 7.3.5. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 8.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 8.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Source 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Source 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 9.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 9.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Source 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Source 9.3.3. By Application 9.4. Key Takeaways 10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Source 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Source 10.3.3. By Application 10.4. Key Takeaways 11. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.1.4. Malaysia 11.2.1.5. Singapore 11.2.1.6. Australia 11.2.1.7. New Zealand 11.2.1.8. Rest of APAC 11.2.2. By Source 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Source 11.3.3. By Application 11.4. Key Takeaways 12. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. GCC Countries 12.2.1.2. South Africa 12.2.1.3. Israel 12.2.1.4. Rest of MEA 12.2.2. By Source 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Source 12.3.3. By Application 12.4. Key Takeaways 13. Key Countries Market Analysis 13.1. U.S. 13.1.1. Pricing Analysis 13.1.2. Market Share Analysis, 2021 13.1.2.1. By Source 13.1.2.2. By Application 13.2. Canada 13.2.1. Pricing Analysis 13.2.2. Market Share Analysis, 2021 13.2.2.1. By Source 13.2.2.2. By Application 13.3. Brazil 13.3.1. Pricing Analysis 13.3.2. Market Share Analysis, 2021 13.3.2.1. By Source 13.3.2.2. By Application 13.4. Mexico 13.4.1. Pricing Analysis 13.4.2. Market Share Analysis, 2021 13.4.2.1. By Source 13.4.2.2. By Application 13.5. Germany 13.5.1. Pricing Analysis 13.5.2. Market Share Analysis, 2021 13.5.2.1. By Source 13.5.2.2. By Application 13.6. U.K. 13.6.1. Pricing Analysis 13.6.2. Market Share Analysis, 2021 13.6.2.1. By Source 13.6.2.2. By Application 13.7. France 13.7.1. Pricing Analysis 13.7.2. Market Share Analysis, 2021 13.7.2.1. By Source 13.7.2.2. By Application 13.8. Spain 13.8.1. Pricing Analysis 13.8.2. Market Share Analysis, 2021 13.8.2.1. By Source 13.8.2.2. By Application 13.9. Italy 13.9.1. Pricing Analysis 13.9.2. Market Share Analysis, 2021 13.9.2.1. By Source 13.9.2.2. By Application 13.10. China 13.10.1. Pricing Analysis 13.10.2. Market Share Analysis, 2021 13.10.2.1. By Source 13.10.2.2. By Application 13.11. Japan 13.11.1. Pricing Analysis 13.11.2. Market Share Analysis, 2021 13.11.2.1. By Source 13.11.2.2. By Application 13.12. South Korea 13.12.1. Pricing Analysis 13.12.2. Market Share Analysis, 2021 13.12.2.1. By Source 13.12.2.2. By Application 13.13. Malaysia 13.13.1. Pricing Analysis 13.13.2. Market Share Analysis, 2021 13.13.2.1. By Source 13.13.2.2. By Application 13.14. Singapore 13.14.1. Pricing Analysis 13.14.2. Market Share Analysis, 2021 13.14.2.1. By Source 13.14.2.2. By Application 13.15. Australia 13.15.1. Pricing Analysis 13.15.2. Market Share Analysis, 2021 13.15.2.1. By Source 13.15.2.2. By Application 13.16. New Zealand 13.16.1. Pricing Analysis 13.16.2. Market Share Analysis, 2021 13.16.2.1. By Source 13.16.2.2. By Application 13.17. GCC Countries 13.17.1. Pricing Analysis 13.17.2. Market Share Analysis, 2021 13.17.2.1. By Source 13.17.2.2. By Application 13.18. South Africa 13.18.1. Pricing Analysis 13.18.2. Market Share Analysis, 2021 13.18.2.1. By Source 13.18.2.2. By Application 13.19. Israel 13.19.1. Pricing Analysis 13.19.2. Market Share Analysis, 2021 13.19.2.1. By Source 13.19.2.2. By Application 14. Market Structure Analysis 14.1. Competition Dashboard 14.2. Competition Benchmarking 14.3. Market Share Analysis of Top Players 14.3.1. By Regional 14.3.2. By Source 14.3.3. By Application 15. Competition Analysis 15.1. Competition Deep Dive 15.1.1. Archer Daniels Midland Company 15.1.1.1. Overview 15.1.1.2. Product Portfolio 15.1.1.3. Profitability by Market Segments 15.1.1.4. Sales Footprint 15.1.1.5. Strategy Overview 15.1.1.5.1. Marketing Strategy 15.1.1.5.2. Product Strategy 15.1.1.5.3. Channel Strategy 15.1.2. Croda International Plc 15.1.2.1. Overview 15.1.2.2. Product Portfolio 15.1.2.3. Profitability by Market Segments 15.1.2.4. Sales Footprint 15.1.2.5. Strategy Overview 15.1.2.5.1. Marketing Strategy 15.1.2.5.2. Product Strategy 15.1.2.5.3. Channel Strategy 15.1.3. Bunge Ltd. 15.1.3.1. Overview 15.1.3.2. Product Portfolio 15.1.3.3. Profitability by Market Segments 15.1.3.4. Sales Footprint 15.1.3.5. Strategy Overview 15.1.3.5.1. Marketing Strategy 15.1.3.5.2. Product Strategy 15.1.3.5.3. Channel Strategy 15.1.4. Cargill, Inc. 15.1.4.1. Overview 15.1.4.2. Product Portfolio 15.1.4.3. Profitability by Market Segments 15.1.4.4. Sales Footprint 15.1.4.5. Strategy Overview 15.1.4.5.1. Marketing Strategy 15.1.4.5.2. Product Strategy 15.1.4.5.3. Channel Strategy 15.1.5. Wilmar International Ltd. 15.1.5.1. Overview 15.1.5.2. Product Portfolio 15.1.5.3. Profitability by Market Segments 15.1.5.4. Sales Footprint 15.1.5.5. Strategy Overview 15.1.5.5.1. Marketing Strategy 15.1.5.5.2. Product Strategy 15.1.5.5.3. Channel Strategy 15.1.6. Kewpie Corporation 15.1.6.1. Overview 15.1.6.2. Product Portfolio 15.1.6.3. Profitability by Market Segments 15.1.6.4. Sales Footprint 15.1.6.5. Strategy Overview 15.1.6.5.1. Marketing Strategy 15.1.6.5.2. Product Strategy 15.1.6.5.3. Channel Strategy 15.1.7. Lasenor Emul SL 15.1.7.1. Overview 15.1.7.2. Product Portfolio 15.1.7.3. Profitability by Market Segments 15.1.7.4. Sales Footprint 15.1.7.5. Strategy Overview 15.1.7.5.1. Marketing Strategy 15.1.7.5.2. Product Strategy 15.1.7.5.3. Channel Strategy 15.1.8. Lecico GmbH 15.1.8.1. Overview 15.1.8.2. Product Portfolio 15.1.8.3. Profitability by Market Segments 15.1.8.4. Sales Footprint 15.1.8.5. Strategy Overview 15.1.8.5.1. Marketing Strategy 15.1.8.5.2. Product Strategy 15.1.8.5.3. Channel Strategy 15.1.9. Lipoid GmbH 15.1.9.1. Overview 15.1.9.2. Product Portfolio 15.1.9.3. Profitability by Market Segments 15.1.9.4. Sales Footprint 15.1.9.5. Strategy Overview 15.1.9.5.1. Marketing Strategy 15.1.9.5.2. Product Strategy 15.1.9.5.3. Channel Strategy 15.1.10. VAV Life Sciences Pvt. Ltd 15.1.10.1. Overview 15.1.10.2. Product Portfolio 15.1.10.3. Profitability by Market Segments 15.1.10.4. Sales Footprint 15.1.10.5. Strategy Overview 15.1.10.5.1. Marketing Strategy 15.1.10.5.2. Product Strategy 15.1.10.5.3. Channel Strategy 16. Assumptions & Acronyms Used 17. Research Methodolog
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Market Volume (Tons) Forecast by Region, 2017-2032
Table 3: Global Market Value (US$ Mn) Forecast by Source, 2017-2032
Table 4: Global Market Volume (Tons) Forecast by Source, 2017-2032
Table 5: Global Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 6: Global Market Volume (Tons) Forecast by Application, 2017-2032
Table 7: North America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: North America Market Volume (Tons) Forecast by Country, 2017-2032
Table 9: North America Market Value (US$ Mn) Forecast by Source, 2017-2032
Table 10: North America Market Volume (Tons) Forecast by Source, 2017-2032
Table 11: North America Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 12: North America Market Volume (Tons) Forecast by Application, 2017-2032
Table 13: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Latin America Market Volume (Tons) Forecast by Country, 2017-2032
Table 15: Latin America Market Value (US$ Mn) Forecast by Source, 2017-2032
Table 16: Latin America Market Volume (Tons) Forecast by Source, 2017-2032
Table 17: Latin America Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 18: Latin America Market Volume (Tons) Forecast by Application, 2017-2032
Table 19: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 20: Europe Market Volume (Tons) Forecast by Country, 2017-2032
Table 21: Europe Market Value (US$ Mn) Forecast by Source, 2017-2032
Table 22: Europe Market Volume (Tons) Forecast by Source, 2017-2032
Table 23: Europe Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 24: Europe Market Volume (Tons) Forecast by Application, 2017-2032
Table 25: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: Asia Pacific Market Volume (Tons) Forecast by Country, 2017-2032
Table 27: Asia Pacific Market Value (US$ Mn) Forecast by Source, 2017-2032
Table 28: Asia Pacific Market Volume (Tons) Forecast by Source, 2017-2032
Table 29: Asia Pacific Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 30: Asia Pacific Market Volume (Tons) Forecast by Application, 2017-2032
Table 31: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 32: MEA Market Volume (Tons) Forecast by Country, 2017-2032
Table 33: MEA Market Value (US$ Mn) Forecast by Source, 2017-2032
Table 34: MEA Market Volume (Tons) Forecast by Source, 2017-2032
Table 35: MEA Market Value (US$ Mn) Forecast by Application, 2017-2032
Table 36: MEA Market Volume (Tons) Forecast by Application, 2017-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) by Source, 2022-2032
Figure 2: Global Market Value (US$ Mn) by Application, 2022-2032
Figure 3: Global Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 5: Global Market Volume (Tons) Analysis by Region, 2017-2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Market Value (US$ Mn) Analysis by Source, 2017-2032
Figure 9: Global Market Volume (Tons) Analysis by Source, 2017-2032
Figure 10: Global Market Value Share (%) and BPS Analysis by Source, 2022-2032
Figure 11: Global Market Y-o-Y Growth (%) Projections by Source, 2022-2032
Figure 12: Global Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 13: Global Market Volume (Tons) Analysis by Application, 2017-2032
Figure 14: Global Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 15: Global Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 16: Global Market Attractiveness by Source, 2022-2032
Figure 17: Global Market Attractiveness by Application, 2022-2032
Figure 18: Global Market Attractiveness by Region, 2022-2032
Figure 19: North America Market Value (US$ Mn) by Source, 2022-2032
Figure 20: North America Market Value (US$ Mn) by Application, 2022-2032
Figure 21: North America Market Value (US$ Mn) by Country, 2022-2032
Figure 22: North America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 23: North America Market Volume (Tons) Analysis by Country, 2017-2032
Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 26: North America Market Value (US$ Mn) Analysis by Source, 2017-2032
Figure 27: North America Market Volume (Tons) Analysis by Source, 2017-2032
Figure 28: North America Market Value Share (%) and BPS Analysis by Source, 2022-2032
Figure 29: North America Market Y-o-Y Growth (%) Projections by Source, 2022-2032
Figure 30: North America Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 31: North America Market Volume (Tons) Analysis by Application, 2017-2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 34: North America Market Attractiveness by Source, 2022-2032
Figure 35: North America Market Attractiveness by Application, 2022-2032
Figure 36: North America Market Attractiveness by Country, 2022-2032
Figure 37: Latin America Market Value (US$ Mn) by Source, 2022-2032
Figure 38: Latin America Market Value (US$ Mn) by Application, 2022-2032
Figure 39: Latin America Market Value (US$ Mn) by Country, 2022-2032
Figure 40: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 41: Latin America Market Volume (Tons) Analysis by Country, 2017-2032
Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 44: Latin America Market Value (US$ Mn) Analysis by Source, 2017-2032
Figure 45: Latin America Market Volume (Tons) Analysis by Source, 2017-2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Source, 2022-2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Source, 2022-2032
Figure 48: Latin America Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 49: Latin America Market Volume (Tons) Analysis by Application, 2017-2032
Figure 50: Latin America Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 51: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 52: Latin America Market Attractiveness by Source, 2022-2032
Figure 53: Latin America Market Attractiveness by Application, 2022-2032
Figure 54: Latin America Market Attractiveness by Country, 2022-2032
Figure 55: Europe Market Value (US$ Mn) by Source, 2022-2032
Figure 56: Europe Market Value (US$ Mn) by Application, 2022-2032
Figure 57: Europe Market Value (US$ Mn) by Country, 2022-2032
Figure 58: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 59: Europe Market Volume (Tons) Analysis by Country, 2017-2032
Figure 60: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 61: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 62: Europe Market Value (US$ Mn) Analysis by Source, 2017-2032
Figure 63: Europe Market Volume (Tons) Analysis by Source, 2017-2032
Figure 64: Europe Market Value Share (%) and BPS Analysis by Source, 2022-2032
Figure 65: Europe Market Y-o-Y Growth (%) Projections by Source, 2022-2032
Figure 66: Europe Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 67: Europe Market Volume (Tons) Analysis by Application, 2017-2032
Figure 68: Europe Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 69: Europe Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 70: Europe Market Attractiveness by Source, 2022-2032
Figure 71: Europe Market Attractiveness by Application, 2022-2032
Figure 72: Europe Market Attractiveness by Country, 2022-2032
Figure 73: Asia Pacific Market Value (US$ Mn) by Source, 2022-2032
Figure 74: Asia Pacific Market Value (US$ Mn) by Application, 2022-2032
Figure 75: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032
Figure 76: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 77: Asia Pacific Market Volume (Tons) Analysis by Country, 2017-2032
Figure 78: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 79: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 80: Asia Pacific Market Value (US$ Mn) Analysis by Source, 2017-2032
Figure 81: Asia Pacific Market Volume (Tons) Analysis by Source, 2017-2032
Figure 82: Asia Pacific Market Value Share (%) and BPS Analysis by Source, 2022-2032
Figure 83: Asia Pacific Market Y-o-Y Growth (%) Projections by Source, 2022-2032
Figure 84: Asia Pacific Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 85: Asia Pacific Market Volume (Tons) Analysis by Application, 2017-2032
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 88: Asia Pacific Market Attractiveness by Source, 2022-2032
Figure 89: Asia Pacific Market Attractiveness by Application, 2022-2032
Figure 90: Asia Pacific Market Attractiveness by Country, 2022-2032
Figure 91: MEA Market Value (US$ Mn) by Source, 2022-2032
Figure 92: MEA Market Value (US$ Mn) by Application, 2022-2032
Figure 93: MEA Market Value (US$ Mn) by Country, 2022-2032
Figure 94: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 95: MEA Market Volume (Tons) Analysis by Country, 2017-2032
Figure 96: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 97: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 98: MEA Market Value (US$ Mn) Analysis by Source, 2017-2032
Figure 99: MEA Market Volume (Tons) Analysis by Source, 2017-2032
Figure 100: MEA Market Value Share (%) and BPS Analysis by Source, 2022-2032
Figure 101: MEA Market Y-o-Y Growth (%) Projections by Source, 2022-2032
Figure 102: MEA Market Value (US$ Mn) Analysis by Application, 2017-2032
Figure 103: MEA Market Volume (Tons) Analysis by Application, 2017-2032
Figure 104: MEA Market Value Share (%) and BPS Analysis by Application, 2022-2032
Figure 105: MEA Market Y-o-Y Growth (%) Projections by Application, 2022-2032
Figure 106: MEA Market Attractiveness by Source, 2022-2032
Figure 107: MEA Market Attractiveness by Application, 2022-2032
Figure 108: MEA Market Attractiveness by Country, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the global Phospholipids Market currently worth?
The global Phospholipids market was valued at US$ 3.8 Bn in 2022.
What is the Phospholipids market Forecast through 2032?
The Phospholipids market is set to witness a growth rate of 7.3% over the forecast period and be valued at US$ 7.8 Bn by 2032.
Which source of Phospholipids is driving phospholipids market demand?
Soy-derived Phospholipids are driving the phospholipids market demand.
Which are the top 5 countries driving the highest sales of Phospholipids?
US, UK, China, Japan, and South Korea are expected to be the major drivers of sales.
What is the US market outlook for Phospholipids?
The US accounts for nearly 32% of the global market.
At what rate did demand for Phospholipids increase over the past years?
The Phospholipids market expanded at 5.4% from 2015 through 2021.
Who are the key players shaping the Phospholipids Industry?
Archer Daniels Midland Company, Croda International Plc., Bunge Ltd., Cargill, Inc., Kewpie Corporation, Lasenor Emul SL, Lecico GmbH, Lipoid GmbH, Sime Darby Unimills B.V. SojaProtein a.d., Stern-Wywiol Gruppe, VAV Life Sciences Pvt. Ltd., and Wilmar Int
Phospholipids Market